Q3 2024 EPS Estimates for TriMas Co. (NASDAQ:TRS) Decreased by Zacks Research

TriMas Co. (NASDAQ:TRS - Free Report) - Stock analysts at Zacks Research lowered their Q3 2024 earnings per share estimates for shares of TriMas in a research note issued to investors on Wednesday, August 23rd. Zacks Research analyst M. Das now forecasts that the industrial products company will post earnings of $0.59 per share for the quarter, down from their prior forecast of $0.62. The consensus estimate for TriMas' current full-year earnings is $1.91 per share. Zacks Research also issued estimates for TriMas' FY2024 earnings at $2.20 EPS.

TriMas (NASDAQ:TRS - Get Free Report) last released its quarterly earnings results on Thursday, July 27th. The industrial products company reported $0.50 earnings per share for the quarter, meeting the consensus estimate of $0.50. The business had revenue of $233.19 million for the quarter, compared to analysts' expectations of $255.81 million. TriMas had a net margin of 5.52% and a return on equity of 9.71%. The firm's revenue for the quarter was down 1.9% compared to the same quarter last year. During the same quarter in the previous year, the business posted $0.60 earnings per share.

TRS has been the topic of a number of other research reports. TheStreet cut shares of TriMas from a "b" rating to a "c" rating in a report on Monday, May 1st. StockNews.com started coverage on TriMas in a research report on Thursday, August 17th. They set a "hold" rating for the company. Finally, BWS Financial assumed coverage on TriMas in a research note on Monday, May 22nd. They issued a "buy" rating and a $40.00 target price on the stock.

Check Out Our Latest Research Report on TriMas

Shares of TRS stock opened at $25.68 on Monday. The company has a current ratio of 2.70, a quick ratio of 1.50 and a debt-to-equity ratio of 0.63. The company's fifty day moving average price is $26.67 and its 200-day moving average price is $27.21. The stock has a market cap of $1.06 billion, a PE ratio of 22.33 and a beta of 0.72. TriMas has a 12 month low of $21.41 and a 12 month high of $31.89.

The firm also recently announced a quarterly dividend, which was paid on Thursday, August 10th. Shareholders of record on Thursday, August 3rd were issued a $0.04 dividend. This represents a $0.16 dividend on an annualized basis and a dividend yield of 0.62%. The ex-dividend date of this dividend was Wednesday, August 2nd. TriMas's payout ratio is 13.91%.

In other TriMas news, CAO Paul Swart sold 5,500 shares of the business's stock in a transaction dated Friday, July 28th. The stock was sold at an average price of $27.41, for a total value of $150,755.00. Following the completion of the transaction, the chief accounting officer now owns 26,749 shares of the company's stock, valued at approximately $733,190.09. The sale was disclosed in a legal filing with the SEC, which is available through this link. In other TriMas news, CAO Paul Swart sold 5,500 shares of the business's stock in a transaction on Friday, July 28th. The shares were sold at an average price of $27.41, for a total transaction of $150,755.00. Following the completion of the sale, the chief accounting officer now directly owns 26,749 shares in the company, valued at approximately $733,190.09. The sale was disclosed in a document filed with the SEC, which is available through this link. Also, CFO Scott A. Mell sold 1,200 shares of the firm's stock in a transaction on Thursday, August 3rd. The stock was sold at an average price of $25.80, for a total value of $30,960.00. Following the completion of the transaction, the chief financial officer now owns 25,664 shares in the company, valued at $662,131.20. The disclosure for this sale can be found here. Corporate insiders own 1.10% of the company's stock.

A number of institutional investors have recently bought and sold shares of the stock. Tower Research Capital LLC TRC raised its stake in shares of TriMas by 90.7% in the first quarter. Tower Research Capital LLC TRC now owns 1,144 shares of the industrial products company's stock worth $32,000 after buying an additional 544 shares during the period. Ellevest Inc. raised its position in shares of TriMas by 30.6% during the 1st quarter. Ellevest Inc. now owns 2,791 shares of the industrial products company's stock valued at $78,000 after purchasing an additional 654 shares during the period. UBS Group AG lifted its stake in shares of TriMas by 80.9% during the 3rd quarter. UBS Group AG now owns 3,614 shares of the industrial products company's stock valued at $91,000 after buying an additional 1,616 shares in the last quarter. PNC Financial Services Group Inc. boosted its holdings in TriMas by 182.2% in the 1st quarter. PNC Financial Services Group Inc. now owns 2,912 shares of the industrial products company's stock worth $94,000 after buying an additional 1,880 shares during the period. Finally, Acadian Asset Management LLC purchased a new stake in TriMas in the 1st quarter worth $152,000. 99.86% of the stock is owned by institutional investors.

TriMas Corporation engages in the design, development, manufacture, and sale of products for consumer products, aerospace, and industrial markets worldwide. It operates through three segments: Packaging, Aerospace, and Specialty Products. The Packaging segment offers dispensing products, such as foaming and sanitizer pumps, lotion and hand soap pumps, beverage dispensers, perfume sprayers, and nasal and trigger sprayers; polymeric and steel caps and closures comprising food lids, flip-top and beverage closures, child resistance caps, drum and pail closures, and flexible spouts; polymeric jar products; integrated dispensers; bag-in-box products; and consumable vascular delivery and diagnostic test components under the Rieke, Taplast, Affaba & Ferrari, Intertech, Omega, and Rapak brands.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to [email protected].

Before you consider TriMas, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and TriMas wasn't on the list.

While TriMas currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Which stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.